9IDM
Human Deoxyhypusine Synthase Fragment Screening Campaign - ligand VT00175
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | MAX IV BEAMLINE BioMAX |
| Synchrotron site | MAX IV |
| Beamline | BioMAX |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2021-11-13 |
| Detector | DECTRIS EIGER2 X 16M |
| Wavelength(s) | 0.9763 |
| Spacegroup name | P 32 2 1 |
| Unit cell lengths | 105.160, 105.160, 160.310 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 46.090 - 1.430 |
| R-factor | 0.18498 |
| Rwork | 0.184 |
| R-free | 0.20098 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.018 |
| RMSD bond angle | 1.858 |
| Data reduction software | XDS |
| Data scaling software | XDS |
| Phasing software | DIMPLE |
| Refinement software | REFMAC (5.8.0419) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 46.090 | 46.090 | 1.520 |
| High resolution limit [Å] | 1.430 | 4.270 | 1.430 |
| Rmerge | 0.071 | 0.041 | 2.085 |
| Rmeas | 0.075 | 0.043 | 2.204 |
| Number of reflections | 188836 | 7480 | 30261 |
| <I/σ(I)> | 14.19 | 53.43 | 0.89 |
| Completeness [%] | 100.0 | ||
| Redundancy | 11.13 | ||
| CC(1/2) | 0.999 | 0.999 | 0.605 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293 | 0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix (MPD, PEG 1000, PEG 3350), 100 mM Tris-Bicine pH = 8.5 |






